Skip to content

Clinical trials

Phase 2 Hyperlipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 2 Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20043
20051
20067
20075
20083
20092
20101
20116
20123
20131
20142
20153
20163
20173
20181
20192
20204
20213
20221
20231
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Unknown status5
Terminated4
Recruiting3
Active, not recruiting3
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Toronto5
Amgen4
Akcea Therapeutics3
AstraZeneca3
Kastle Therapeutics, LLC3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Takeda3
Aegerion Pharmaceuticals, Inc.2
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh2
Esperion Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias77
Hypercholesterolemia20
Dyslipidemias19
Cardiovascular Diseases15
Lipid Metabolism Disorders10
Metabolic Diseases8
Diabetes Mellitus7
Hypertension7
Hypertriglyceridemia5
Insulin Resistance5

Trials

Showing 51 to 75 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.